Insider Buying: The Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director Just Bought 2.8% More Shares

Whilst it may not be a huge deal, we thought it was good to see that the Lotus Eye Hospital and Institute Limited (NSE:LOTUSEYE) MD & Whole Time Director, Sangeetha Sundaramoorthy, recently bought ₹198k worth of stock, for ₹31.88 per share. However, it only increased their shares held by 2.8%, and it wasn't a huge purchase by absolute value, either.

See our latest analysis for Lotus Eye Hospital and Institute

Lotus Eye Hospital and Institute Insider Transactions Over The Last Year

While no particular insider transaction stood out, we can still look at the overall trading.

Lotus Eye Hospital and Institute insiders may have bought shares in the last year, but they didn't sell any. Their average price was about ₹26.41. It's great to see insiders putting their own cash into the company's stock, albeit at below the recent share price (₹32.25). You can see the insider transactions (by companies and individuals) over the last year depicted in the chart below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Does Lotus Eye Hospital and Institute Boast High Insider Ownership?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. A high insider ownership often makes company leadership more mindful of shareholder interests. Lotus Eye Hospital and Institute insiders own about ₹459m worth of shares (which is 69% of the company). This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

So What Do The Lotus Eye Hospital and Institute Insider Transactions Indicate?

It's certainly positive to see the recent insider purchases. And the longer term insider transactions also give us confidence. But on the other hand, the company made a loss during the last year, which makes us a little cautious. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about Lotus Eye Hospital and Institute. Looks promising! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Lotus Eye Hospital and Institute. To help with this, we've discovered 2 warning signs (1 is concerning!) that you ought to be aware of before buying any shares in Lotus Eye Hospital and Institute.

Of course Lotus Eye Hospital and Institute may not be the best stock to buy. So you may wish to see this free collection of high quality companies.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

When trading Lotus Eye Hospital and Institute or any other investment, use the platform considered by many to be the Professional's Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
^*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.